title: H2 Treatment Attenuated Pain Behavior and Cytokine Release Through the HO-1/CO Pathway in a Rat Model of Neuropathic Pain.
abstract: Neuropathic pain (NP) is characterized by persistent pain, tactile allodynia, or hyperalgesia. Peripheral nerve injury contributes to rapid progress of inflammatory response and simultaneously generates neuropathic pain. Hydrogen (H2) has anti-inflammation, anti-apoptosis, and anti-oxidative stress effects. Therefore, we hypothesized that H2 treatment could alleviate allodynic and hyperalgesic behaviors and the release of inflammatory factors in rats with neuropathic pain. Peripheral neuropathic pain was established by chronic constriction injury of sciatic nerve in rats. H2 was given twice through intraperitoneal injection at a daily dose of 10 mL/kg during days 1-7 after the operation. Hyperalgesia and allodynia were tested, pro-inflammatory factors of dorsal root ganglia (DRG) and the spinal cord were measured by enzyme-linked immunosorbent assay (ELISA) during days 1-14 after the operation, and heme oxygenase (HO)-1 messenger RNA (mRNA) and protein expression and activities were measured at day 14 after sciatic nerve injury in rats. After Sn (IV) protoporphyrin IX dihydrochloride (SnPP)-IX, hemin, and carbon monoxide-releasing molecule (CORM)-2 had been given for chronic constriction injury (CCI) in rats, the above indicators were assessed. We found that H2 clearly inhibited hyperalgesia and allodynia in neuropathic pain and also attenuated the pro-inflammatory cytokines TNF-α, IL-1β, and high-mobility group box (HMGB) 1. H2 improved HO-1 mRNA and protein expression and activities in the process of pain. SnPP-IX reversed the inhibitory effect of H2 on hyperalgesia and allodynia and on pro-inflammatory cytokines in DRG and the spinal cord. The antinociceptive and anti-inflammatory effects of H2 were involved in the activation of HO-1/CO signaling during neuropathic pain in rats.
authors.affiliation: Department of Anesthesiology, Tianjin Research Institute of Anesthesiology, Tianjin Medical University General Hospital, 154 Anshan Road, Tianjin, 300052, People's Republic of China.
authors.forename: Yajun
authors.initials: Y
authors.lastname: Chen
authors.forename: Hongguang
authors.initials: H
authors.lastname: Chen
authors.forename: Keliang
authors.initials: K
authors.lastname: Xie
authors.forename: Lingling
authors.initials: L
authors.lastname: Liu
authors.forename: Yuan
authors.initials: Y
authors.lastname: Li
authors.forename: Yonghao
authors.initials: Y
authors.lastname: Yu
authors.forename: Guolin
authors.initials: G
authors.lastname: Wang
mesh_terms: D000818:Animals; D002248:Carbon Monoxide / Q000378:metabolism*; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004195:Disease Models, Animal; D051547:Heme Oxygenase-1 / Q000096:biosynthesis*; D006859:Hydrogen / Q000627:therapeutic use*; D008297:Male; D009437:Neuralgia / Q000188:drug therapy / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D016207:Cytokines; D002248:Carbon Monoxide; D006859:Hydrogen; D051547:Heme Oxygenase-1
references.citation: Shock. 2010 Nov;34(5):495-501
references.pmid: 20351628
references.citation: Neurosci Lett. 2008 May 9;436(2):210-3
references.pmid: 18394803
references.citation: Eur J Pharmacol. 2010 Dec 1;648(1-3):102-9
references.pmid: 20846523
references.citation: Pain. 2008 Apr;135(3):232-9
references.pmid: 17689191
references.citation: J Neuroinflammation. 2005 Nov 18;2:26
references.pmid: 16287511
references.citation: Pain. 2008 Jul 15;137(2):332-9
references.pmid: 17964723
references.citation: Biochem Biophys Res Commun. 2008 Aug 15;373(1):30-5
references.pmid: 18541148
references.citation: Brain Behav Immun. 2011 Oct;25(7):1322-32
references.pmid: 21496480
references.citation: J Neurosci Methods. 1994 Jul;53(1):55-63
references.pmid: 7990513
references.citation: J Mol Neurosci. 2014 Sep;54(1):137-46
references.pmid: 24573601
references.citation: Pain. 2010 Jun;149(3):514-21
references.pmid: 20392563
references.citation: J Neurosci Res. 2011 Jun;89(6):802-7
references.pmid: 21425317
references.citation: PLoS One. 2014 Jun 18;9(6):e100352
references.pmid: 24941001
references.citation: Anesthesiology. 2013 May;118(5):1180-97
references.pmid: 23358127
references.citation: Med J Aust. 2012 Apr 2;196(6):404-5
references.pmid: 22471543
references.citation: J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):116-23
references.pmid: 23087256
references.citation: Nat Med. 2008 Mar;14(3):331-6
references.pmid: 18264108
references.citation: Eur J Pharmacol. 2010 May 25;634(1-3):184-91
references.pmid: 20184873
references.citation: Pain. 2009 Nov;146(1-2):75-83
references.pmid: 19660867
references.citation: Pain. 1999 Jan;79(1):31-7
references.pmid: 9928773
references.citation: Brain Res Rev. 2007 Nov;56(1):148-69
references.pmid: 17706291
references.citation: Brain Behav Immun. 2007 Jul;21(5):553-60
references.pmid: 17204395
references.citation: Pain. 2011 Aug;152(8):1872-87
references.pmid: 21620566
references.citation: Neurosci Lett. 2011 Nov 21;505(3):254-9
references.pmid: 22037228
references.citation: J Neurosci. 2003 Feb 1;23 (3):1026-40
references.pmid: 12574433
references.citation: Brain. 2014 Mar;137(Pt 3):724-38
references.pmid: 24369380
references.citation: Neurosci Lett. 1992 Dec 14;148(1-2):76-80
references.pmid: 1300507
references.citation: Biochem Biophys Res Commun. 2010 May 14;395(4):572-6
references.pmid: 20399746
references.citation: Int J Surg. 2013;11(10 ):1060-6
references.pmid: 24148794
references.citation: Annu Rev Immunol. 2011;29:139-62
references.pmid: 21219181
references.citation: Rheumatology (Oxford). 2008 Sep;47(9):1323-8
references.pmid: 18621749
references.citation: Circ Res. 2002 Feb 8;90(2):E17-24
references.pmid: 11834719
references.citation: Br J Pharmacol. 2001 Apr;132(8):1673-82
references.pmid: 11309238
references.citation: Nat Med. 2007 Jun;13(6):688-94
references.pmid: 17486089
references.citation: Shock. 2010 Jul;34(1):90-7
references.pmid: 19997046
references.citation: Pharmacol Ther. 2006 Oct;112(1):116-38
references.pmid: 16730375
references.citation: J Neurosci. 2008 May 14;28(20):5189-94
references.pmid: 18480275
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):102-8
references.pmid: 12490580
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386(1):79-90
references.pmid: 23224421
references.citation: J Ethnopharmacol. 2012 Aug 1;142(3):723-31
references.pmid: 22706151
references.citation: Pain. 2001 Feb 1;90(1-2):1-6
references.pmid: 11166964
references.citation: Can J Neurol Sci. 2013 Nov;40(6):857-63
references.pmid: 24257230
references.citation: Nat Neurosci. 2007 Nov;10(11):1361-8
references.pmid: 17965656
references.citation: J Neurosci. 2011 Aug 31;31(35):12533-42
references.pmid: 21880915
references.citation: Brain. 2005 Apr;128(Pt 4):854-66
references.pmid: 15689362
references.citation: Pain. 1988 Apr;33(1):87-107
references.pmid: 2837713
references.citation: BMC Neurosci. 2011 Nov 23;12:120
references.pmid: 22111979
references.citation: Shock. 2012 Dec;38(6):656-63
references.pmid: 23160520
references.citation: J Neuroimmune Pharmacol. 2013 Mar;8(1):202-11
references.pmid: 23242694